Chinese Journal of Digestive Surgery
2024:
2023:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
- Issue S1 |
2022:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
- Issue S1 |
2021:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
- Issue S1 |
- Issue S2 |
2020:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
- Issue S1 |
- Issue Z1 |
2019:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2018:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2017:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2016:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2015:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2014:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2013:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2012:
2011:
2010:
2009:
2008:
2007:
2006:
2005:
2004:
2003:
2002:
Chinese Journal of Digestive Surgery
Clinical efficacy of atezolizumab plus bevacizumab in the first-line treatment of advanced huge hepatocellular carcinoma
Chinese Journal of Digestive Surgery, Volume 21, Issue S1,2022, Pages 35-40, doi:10.3760/cma.j.cn115610-20220927-00553
序三
Chinese Journal of Digestive Surgery, Volume 21, Issue S1,2022, Pages F4, doi:10.3760/cma.j.issn.1673-9752.2022.S1.104
Clinical efficacy of immunotherapy plus targeted therapy combined with local treatment for unresectable hepatocellular carcinoma
Chinese Journal of Digestive Surgery, Volume 21, Issue S1,2022, Pages 25-28, doi:10.3760/cma.j.cn115610-20220929-00559
序二
Chinese Journal of Digestive Surgery, Volume 21, Issue S1,2022, Pages F3, doi:10.3760/cma.j.issn.1673-9752.2022.S1.103
Clinical efficacy of immune checkpoint inhibitor plus vascular endothelial growth factor inhibitor in the first-line treatment of advanced unresectable hepatocellular carcinoma
Chinese Journal of Digestive Surgery, Volume 21, Issue S1,2022, Pages 29-34, doi:10.3760/cma.j.cn115610-20220824-00469